CTLA4 and neoplasm: When stressed/injured but live tumor cells, generated by etoposide treatment ex vivo, were injected directly into primary mouse tumors, in combination with systemic anti-PD1 and anti-CTLA4 antibody treatment, the animals showed marked tumor regression and prolonged survival compared to treatment with anti-PD1/anti-CTLA4 alone.